Pomerantz LLP is looking into Iovance Biotherapeutics for possible fraud after the company shared its clinical trial results.

Nov 6, 2026, 6:34 PM ETRulesRead the original at natlawreview.com

Bad for IOVA

Pomerantz LLP is investigating whether Iovance misrepresented trial data, raising legal and trust concerns. No finding of wrongdoing is reported, but the investigation is negative for the company.

IOVA · Iovance Biotherapeutics, Inc.

AI read · Bad for IOVA

The AI's read

This adds legal and trust concerns around how Iovance described its trial results. The source reports an investigation, not a finding of wrongdoing, so the concern is possible legal exposure rather than proven misconduct.

Get alerts for IOVA

Follow Iovance Biotherapeutics, Inc. (IOVA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IOVA

Free on the App Store and Google Play, or on the web.